Literature DB >> 8840410

Varicella-zoster virus: overview and clinical manifestations.

A M Arvin1.   

Abstract

Varicella-zoster virus (VZV) is a human pathogen that has probably infected humans since prehistoric times. Varicella-zoster virus causes chickenpox in childhood (varicella), and establishes latency in sensory ganglia after the primary infection. Varicella-zoster virus may reemerge later in life, taking advantage of the decline in immune function that occurs with aging. Varicella-zoster virus reactivation causes herpes zoster, commonly known as shingles. The incidence of herpes zoster increases with advancing age. Severe pain is the major cause of acute and chronic morbidity in patients with herpes zoster. Fortunately, the acute phase is self-limiting and transient. However, chronic and often debilitating pain may persist after the lesions have healed and is referred to as postherpetic neuralgia (PHN), the most common complication of herpes zoster. Similar to acute herpes zoster, the incidence of PHN increases dramatically with age.

Entities:  

Mesh:

Year:  1996        PMID: 8840410

Source DB:  PubMed          Journal:  Semin Dermatol        ISSN: 0278-145X


  11 in total

1.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Dissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus.

Authors:  Christina L Stallings; Saul Silverstein
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.

Authors:  Ottavia Balbi; Savino Baldi; Stefano Rizza; Antonio Pietroiusti; Stefano Perrone; Luca Coppeta
Journal:  Hum Vaccin Immunother       Date:  2020-07-09       Impact factor: 3.452

Review 4.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

5.  Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase.

Authors:  P R Kinchington; K Fite; S E Turse
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.

Authors:  Melissa A Visalli; Brittany L House; Anca Selariu; Hua Zhu; Robert J Visalli
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

7.  BAG3, a host cochaperone, facilitates varicella-zoster virus replication.

Authors:  Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Varicella susceptibility in a Canadian population.

Authors:  S Ratnam
Journal:  Can J Infect Dis       Date:  2000-09

9.  Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.

Authors:  Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Dhwani Govil; Christopher J Birch; Julian D Druce; D Scott Schmid; Margaret C Croxson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

10.  Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation.

Authors:  Celine S Lages; Isabelle Suffia; Paula A Velilla; Bin Huang; Gregg Warshaw; David A Hildeman; Yasmin Belkaid; Claire Chougnet
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.